UK Public Sector Contracts & Tenders

A direct access non-obstetric ultrasound provision for adults. The service is intended to aid early diagnostics and avoid the need for unnecessary referral to secondary care for conditions that can be appropriately managed within a Primary Care setting or to support the shift of activity into a primary care setting. There is a need for an urgent award of contracts for direct access ultrasound and for a period of 12 months (01st April 2025- 31st March 2026) to ensure the MSEFT have sufficient time to procure the CDC capacity. Risk to patient safety through increased (long) waiting times unless an arrangement is in place for 1 April 2025 as all direct access would then be referred into MSEFT who have confirmed they cannot absorb the activity within current capacity. An urgent award is required for continuity of service and safety of patients requiring direct access diagnostics. The current contract with the incumbent (Beehive Solutions Limited) expires on 31st March 2025 and as a consequence there is a requirement to award a 12 month contract from 01st April 2025 to 31st March 2026. The value is a £0 value contract – paid at local prices – planning value for 2024-25 is £726,168 which is subject to any uplift applied to 2025-26.

A direct access non-obstetric ultrasound provision for adults and the service is intended to aid early diagnostics and avoid the need for unnecessary referral to secondary care for conditions that can be appropriately managed within a Primary Care setting or to support the shift of activity into a primary care setting. There is a need for an urgent award of contracts for direct access ultrasound and for a period of 12 months (01st April 2025- 31st March 2026) to ensure the MSEFT have sufficient time to procure the CDC capacity. Risk to patient safety through increased (long) waiting times unless an arrangement is in place for 1 April 2025 as all direct access would then be referred into MSEFT who have confirmed they cannot absorb the activity within current capacity. An urgent award is required for continuity of service and safety of patients requiring direct access diagnostics. The current contract with the incumbent (Diagnostic Healthcare Limited ) expires on 31st March 2025 and as a consequence there is a requirement to award a 12 month contract from 01st April 2025 to 31st March 2026. The value is a £0 value contract – paid at local prices – planning value for 2024-25 is £244,802 which is subject to any uplift applied to 2025-26.

A direct access non-obstetric ultrasound provision for adults. The service is intended to aid early diagnostics and avoid the need for unnecessary referral to secondary care for conditions that can be appropriately managed within a Primary Care setting or to support the shift of activity into a primary care setting. There is a need for an urgent award of contracts for direct access ultrasound and for a period of 12 months (01st April 2025- 31st March 2026) to ensure the MSEFT have sufficient time to procure the CDC capacity. Risk to patient safety through increased (long) waiting times unless an arrangement is in place for 1 April 2025 as all direct access would then be referred into MSEFT who have confirmed they cannot absorb the activity within current capacity. An urgent award is required for continuity of service and safety of patients requiring direct access diagnostics. The current contract with the incumbent (Lakeside Medical Diagnostics Limited ) expires on 31st March 2025 and as a consequence there is a requirement to award a 12 month contract from 01st April 2025 to 31st March 2026. The value is a £0 value contract – paid at local prices – planning value for 2024-25 is £580,657 which is subject to any uplift applied to 2025-26.

There is a need for an urgent award of contracts for direct access endoscopy and for a period of 12 months (01st April 2025- 31st March 2026) to ensure the MSEFT have sufficient time to procure the CDC capacity. Risk to patient safety through increased (long) waiting times unless an arrangement is in place for 1 April 2025 as all direct access would then be referred into MSEFT who have confirmed they cannot absorb the activity within current capacity. An urgent award is required for continuity of service and safety of patients requiring direct access diagnostics. A community based direct access endoscopy service for the population of Mid and South Essex. The service will include gastroscopy, flexible sigmoidoscopy and colonoscopy. The service will include providing uncomplicated diagnostic/treatment and surveillance endoscopy for non-urgent patients presenting with the following conditions: Dyspepsia, Reflux, Abdominal Pain, Diarrhoea, Change in bowel habit, Rectal bleeding and Haemorrhoids. The current contract with the incumbent (Chartwell Private Hospital and Diagnostics Limited) expires on 31st March 2025 and as a consequence there is a requirement to award a 12 month contract from 01st April 2025 to 31st March 2026. The value is a £0 value contract – paid at local prices – planning value for 2024-25 is £833,671 which is subject to any uplift applied to 2025-26.

NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to The Stroke Association to deliver Life After Stroke services to the patients within Mid and South Essex's geographical footprint. The contract will be for twelve months from 01st April 2025 - 31st March 2026. The aggregate contract value is forecasted at £175,032.00. The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 20%. Value 20%. Integration, Collaboration & Service Sustainability 20%, Access Health Inequalities and Choice 20%; Social Value 20%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract.

This is an Intention to Award Notice and is issued in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 under the competitive process. This notice is issued by NHS Mid and South Essex Integrated Care Board (herein the Authority) and relates to the Invitation to Tender (Competitive Process) issued by the Authority for the provision of Tier 3 Specialist Weight Management Services (the Services) in Mid and South Essex. The Authority has undertaken a full evaluation and assessment of the compliant bid submissions received as part of this competitive process, which were evaluated in line with the procurement documentation published within the Competitive Process Overview (CPO). The contract award criteria are specified in the procurement documentation and CPO. As a result of this, the Authority intends to award the proposed Contract for the Service to the Provider that achieved the highest technical and commercial scores across the key criteria used. The purpose of this competitive process was for the Authority to secure a suitably qualified provider to deliver this Tier 3 Specialist Weight Management Service across Mid and South Essex.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to SystemOne for the provision of Core Clinical Systems for the patient population within the Mid and South Essex's geographical footprint. The contract will be for 5 months from 01st November 2024 – 31st March 2025. The aggregate contract value is forecasted at £951,482.00. The Authority shall apply the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a Contract Award Notice to communicate a contract award made by the Contracting Authority; NHS Mid and South Essex Integrated Care Board, (hereinafter referred to as “the Authority”) in compliance with their local standing financial instructions (SFIs). The contract award is made to Kids Inspire for the provision of Children and Young People's Counselling Service across Mid and South Essex. This award is made through a call-off from the Authority's Voluntary and Community Sector Organisation's (VCSO) Pseudo-Dynamic Purchasing System (PDPS) Framework. The process comprised of the following stages: • Stage 1 – Selection from the framework– to ensure bidders had the appropriate capability, skills and capacity to deliver the service, resulting in a list of qualified providers to progress to Stage 2. • Stage 2 – Invitation to Participate – the identified providers at stage one were invited to participate in the process and tender packs sent out for them to formerly express interesting the ICB’s desired award criteria, resulting in the selection of a preferred bidder for contract award. • Stage 3 – Assessment and Recommendation – Assessment of bids received and evaluation and moderation process against key criteria mandated within the Health Care Services (Provider Selection Regime) Regulations 2023 for competitive processes. The contract term is 24 months, commencing 1st April 2025 and expiring on 31st March 2027, at a total aggregate Contract Value of £1,168,600.00. The Authority is publishing this Contract Award Notice in Find a Tender Service in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023.

This is a Contract Award Notice to communicate a contract award for the services entitled' Pan Essex Keyworker Service for Children and Young People with a diagnosed learning disability and/or autism' - by the Contracting Authorities* to HCRG Care Services Limited. The Contract term is 30 months from 1st October 2022 – 31st March 2025 at an aggregate value of £2,421,320 excl. VAT. The Contracting Authorities* (ICB's) are publishing this Contract Award Notice in accordance with the Public Contracts Regulations 2015 (as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020) for spend above £663,540. The Services in scope of this Contract Award Notice fall within social and other specific services within the Public Contracts Regulations 2015 (as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). The Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services. *NHS Suffolk and North East Essex ICB, Mid and South Essex ICB and Hertfordshire and West Essex ICB were formally known at the outset of this procurement as NHS Castle Point and Rochford Clinical Commissioning Group (CCG) (as Coordinating Commissioner), NHS Basildon & Brentwood CCG, NHS Southend CCG, NHS Mid Essex CCG, NHS Thurrock CCG, NHS North East Essex CCG and NHS West Essex CCG.

NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to The Stroke Association to deliver Life After Stroke services to the patients within Mid and South Essex's geographical footprint. The contract will be for 24 months months from 16th April 2026 - 31st March 2028. The aggregate contract value is £401,034 (based on 2 years at annual value of £200,517) The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 20%. Value 20%. Integration, Collaboration & Service Sustainability 20%, Access Health Inequalities and Choice 20%; Social Value 20%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the provision of Improving Access to Phycological Therapies (IAPT) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,884,013.00 As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service. The Authority considers this provider for this IPCC SMI service as technically capable of providing the most economically advantageous solution to the Authority whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Integrated Primary Community Care (IPCC) Severe Mental Illness (SMI) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,329,439.00 As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service. The Authority considers this provider for this IPCC SMI service as technically capable of providing the most economically advantageous solution to the Authority whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032164) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £2,381,000.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032165) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,323,000.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Autism Spectrum Disorder (ASD) Assessments to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032173) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £716,895.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032169) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,063,075.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032170) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £3,019,454.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032162) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,027,687.

NHS Mid and South Essex Integrated Care Board have re-awarded an urgent contract for a 6 month extension for the provision of Community Dermatology and Tele dermatology Virtual Triage and Photography Clinics. This includes delivering the main element of Community Dermatology by the existing main provider- Mayflower Healthcare Alliance Limited and the Tele dermatology Virtual Triage and Photography Clinics Service sub contracting arrangements for the existing sub contract provider ICS Operations Trading as (Xyla) for the Tele dermatology Virtual Triage and Photography Clinics Service. This is under Regulation 14 of the Health Care Services (Provider Selection Regime) Regulations 2023 (PSR 23). This is for a period of 6 months from the 01st October 2025 to the 31th March 2026 as the current Procurement timeline has slipped this urgent award to allow both incumbent providers to continue whilst the mobilisation is undertaken- to ensure continuity and patient safely. This notice is confirmation of an award having been made due to an urgent circumstance and delaying the award of the contract was considered as having been likely to pose a risk to patient or public safety and to protect the health of these patients. The contract is awarded for both providers 1st October 2025 - 31st March 2026. The estimated contract value is for the 6 months is £415,970.80 with a 3-month notice period for Mayflower Healthcare Alliance Limited and £754,752.00 for ICS Operations Trading as (Xyla). The total value for both services is £1170722.80.